Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 2640 | Entrada Therapeutics, Inc.NASDAQ: TRDA | Life Sciences | $196M | 2 | Financial ResultsNov 5, 2026 |
| 2660 | Cartesian Therapeutics, Inc.NASDAQ: RNAC | Life Sciences | $185M | 3 | Financial ResultsNov 5, 2026 |
| 2662 | Palisade Bio, Inc.NASDAQ: PALI | Life Sciences | $185M | 3 | Financial ResultsNov 10, 2026 |
| 2667 | Natures Sunshine Products IncNASDAQ: NATR | Life Sciences | $183M | 3 | Insider BuyingNov 9, 2026 |
| 2680 | Whitehawk Therapeutics, Inc.NASDAQ: WHWK | Life Sciences | $178M | 2 | Financial ResultsNov 9, 2026 |
| 2686 | Korro Bio, Inc.NASDAQ: KRRO | Life Sciences | $174M | 5 | Insider SellingNov 13, 2026 |
| 2692 | Alpha Cognition Inc.NASDAQ: ACOG | Life Sciences | $173M | 6 | Leadership ChangeNov 12, 2026 |
| 2697 | AN2 Therapeutics, Inc.NASDAQ: ANTX | Life Sciences | $170M | 3 | Financial ResultsNov 9, 2026 |
| 2699 | Oramed Pharmaceuticals Inc.NASDAQ: ORMP | Life Sciences | $170M | 4 | Financial ResultsNov 12, 2026 |
| 2700 | Pyxis Oncology, Inc.NASDAQ: PYXS | Life Sciences | $169M | 4 | Other 8-K FilingNov 13, 2026 |
| 2703 | Eledon Pharmaceuticals, Inc.NASDAQ: ELDN | Life Sciences | $166M | 2 | Financial ResultsNov 12, 2026 |
| 2724 | ADC Therapeutics SANYSE: ADCT | Life Sciences | $160M | 4 | Financial ResultsNov 9, 2026 |
| 2726 | Niagen Bioscience, Inc.NASDAQ: NAGE | Life Sciences | $159M | 3 | Earnings CallNov 4, 2026 |
| 2727 | Invivyd, Inc.NASDAQ: IVVD | Life Sciences | $159M | 3 | Financial ResultsNov 16, 2026 |
| 2729 | BridgeBio Oncology Therapeutics, Inc.NASDAQ: BBOT | Life Sciences | $159M | 3 | Financial ResultsNov 10, 2026 |
| 2732 | Zentalis Pharmaceuticals, Inc.NASDAQ: ZNTL | Life Sciences | $157M | 2 | Financial ResultsNov 9, 2026 |
| 2738 | Sutro Biopharma, Inc.NASDAQ: STRO | Life Sciences | $155M | 2 | Financial ResultsNov 12, 2026 |
| 2751 | Humacyte, Inc.NASDAQ: HUMA | Life Sciences | $150M | 3 | Financial ResultsNov 10, 2026 |
| 2757 | Abeona Therapeutics Inc.NASDAQ: ABEO | Life Sciences | $149M | 9 | Insider BuyingNov 16, 2026 |
| 2765 | Protara Therapeutics, Inc.NASDAQ: TARA | Life Sciences | $147M | 2 | Financial ResultsNov 6, 2026 |
| 2781 | Sionna Therapeutics, Inc.NASDAQ: SION | Life Sciences | $141M | 4 | Financial ResultsNov 10, 2026 |
| 2785 | Atrium Therapeutics, Inc.NASDAQ: RNA | Life Sciences | $139M | 6 | Financial ResultsNov 12, 2026 |
| 2786 | Macrogenics IncNASDAQ: MGNX | Life Sciences | $139M | 5 | Investor PresentationNov 13, 2026 |
| 2787 | Fate Therapeutics IncNASDAQ: FATE | Life Sciences | $139M | 4 | Capital RaiseNov 5, 2026 |
| 2804 | Neonc Technologies Holdings, Inc.NASDAQ: NTHI | Life Sciences | $131M | 17 | Investor PresentationNov 17, 2026 |
| 2809 | Alx Oncology Holdings IncNASDAQ: ALXO | Life Sciences | $129M | 3 | Financial ResultsNov 16, 2026 |
| 2820 | enGene Therapeutics Inc.NASDAQ: ENGN | Life Sciences | $127M | 2 | Clinical Trial DataNov 12, 2026 |
| 2822 | Akebia Therapeutics, Inc.NASDAQ: AKBA | Life Sciences | $125M | 5 | Loan & DebtNov 16, 2026 |
| 2830 | Spruce Biosciences, Inc.NASDAQ: SPRB | Life Sciences | $121M | 2 | Financial ResultsNov 9, 2026 |
| 2835 | Lenz Therapeutics, Inc.NASDAQ: LENZ | Life Sciences | $120M | 3 | Financial ResultsNov 3, 2026 |
| 2838 | Compass Therapeutics, Inc.NASDAQ: CMPX | Life Sciences | $119M | 3 | Financial ResultsNov 9, 2026 |
| 2840 | Upstream Bio, Inc.NASDAQ: UPB | Life Sciences | $118M | 2 | Financial ResultsNov 10, 2026 |
| 2851 | Immunic, Inc.NASDAQ: IMUX | Life Sciences | $115M | 4 | Financial ResultsNov 13, 2026 |
| 2867 | Perspective Therapeutics, Inc.NYSE: CATX | Life Sciences | $112M | 14 | Insider BuyingNov 17, 2026 |
| 2868 | OnKure Therapeutics, Inc.NASDAQ: OKUR | Life Sciences | $111M | 2 | Financial ResultsNov 4, 2026 |
| 2869 | Armata Pharmaceuticals, Inc.NYSE: ARMP | Life Sciences | $111M | 4 | Financial ResultsNov 12, 2026 |
| 2870 | Minerva Neurosciences, Inc.NASDAQ: NERV | Life Sciences | $110M | 3 | Investor PresentationNov 16, 2026 |
| 2874 | InMed Pharmaceuticals Inc.NASDAQ: MTRI | Life Sciences | $109M | 12 | M&A DealNov 16, 2026 |
| 2879 | Unicycive Therapeutics, Inc.NASDAQ: UNCY | Life Sciences | $108M | 4 | Financial ResultsNov 16, 2026 |
| 2881 | Foghorn Therapeutics Inc.NASDAQ: FHTX | Life Sciences | $107M | 3 | Financial ResultsNov 9, 2026 |
| 2891 | Organogenesis Holdings Inc.NASDAQ: ORGO | Life Sciences | $104M | 2 | Financial ResultsNov 5, 2026 |
| 2892 | Zura Bio LtdNASDAQ: ZURA | Life Sciences | $104M | 3 | Clinical Trial DataNov 9, 2026 |
| 2893 | Immucell CorpNASDAQ: ICCC | Life Sciences | $104M | 3 | Financial ResultsNov 13, 2026 |
| 2899 | Cue Biopharma, Inc.NASDAQ: CUE | Life Sciences | $102M | 5 | Financial ResultsNov 16, 2026 |
| 2900 | Semnur Pharmaceuticals, Inc.OTC: SMNR | Life Sciences | $102M | 1 | Financial ResultsNov 4, 2026 |
| 2903 | Voyager Therapeutics, Inc.NASDAQ: VYGR | Life Sciences | $101M | 3 | Financial ResultsNov 5, 2026 |
| 2919 | PDS Biotechnology CorpNASDAQ: PDSB | Life Sciences | $97M | 8 | Financial ResultsNov 13, 2026 |
| 2921 | Outlook Therapeutics, Inc.NASDAQ: OTLK | Life Sciences | $96.4M | 2 | Nasdaq/NYSE Compliance NoticeSep 30, 2026 |
| 2930 | Equillium, Inc.NASDAQ: EQ | Life Sciences | $94.7M | 4 | Financial ResultsNov 12, 2026 |
| 2937 | NRX Pharmaceuticals, Inc.NASDAQ: NRXP | Life Sciences | $93.1M | 6 | Financial ResultsNov 16, 2026 |
| 2950 | PMV Pharmaceuticals, Inc.NASDAQ: PMVP | Life Sciences | $89.9M | 3 | Financial ResultsNov 10, 2026 |
| 2952 | Zomedica Corp.OTC: ZOMDF | Life Sciences | $89.2M | 2 | Financial ResultsNov 4, 2026 |
| 2956 | Anixa Biosciences IncNASDAQ: ANIX | Life Sciences | $88.6M | 8 | Insider BuyingNov 2, 2026 |
| 2958 | Black Diamond Therapeutics, Inc.NASDAQ: BDTX | Life Sciences | $87.9M | 2 | Financial ResultsNov 10, 2026 |
| 2960 | Vaxart, Inc.OTC: VXRT | Life Sciences | $87.7M | 4 | Financial ResultsNov 5, 2026 |
| 2961 | TuHURA Biosciences, Inc.NASDAQ: HURA | Life Sciences | $87.5M | 8 | Financial ResultsNov 13, 2026 |
| 2965 | Nkarta, Inc.NASDAQ: NKTX | Life Sciences | $86.8M | 4 | Clinical Trial DataNov 9, 2026 |
| 2979 | Polaryx Therapeutics, Inc.NASDAQ: PLYX | Life Sciences | $83.2M | 2 | Financial ResultsNov 12, 2026 |
| 2981 | Rallybio CorpNASDAQ: RLYB | Life Sciences | $83M | 6 | M&A DealNov 12, 2026 |
| 3007 | Coherus Oncology, Inc.NASDAQ: CHRS | Life Sciences | $78.2M | 3 | Financial ResultsNov 9, 2026 |
| 3008 | Cumberland Pharmaceuticals IncNASDAQ: CPIX | Life Sciences | $78.1M | 8 | Clinical Trial DataNov 16, 2026 |
| 3013 | Jushi Holdings Inc.OTC: JUSH | Life Sciences | $76.7M | 4 | Investor PresentationNov 10, 2026 |
| 3018 | Tenaya Therapeutics, Inc.NASDAQ: TNYA | Life Sciences | $76M | 2 | Financial ResultsNov 4, 2026 |
| 3020 | Anavex Life Sciences Corp.NASDAQ: AVXL | Life Sciences | $75.8M | 5 | Leadership ChangeNov 3, 2026 |
| 3029 | Kala BIO, Inc.NASDAQ: KALA | Life Sciences | $74.1M | 4 | Nasdaq/NYSE Compliance NoticeNov 16, 2026 |
| 3049 | Coya Therapeutics, Inc.NASDAQ: COYA | Life Sciences | $70.4M | 5 | Financial ResultsNov 10, 2026 |
| 3054 | Neumora Therapeutics, Inc.NASDAQ: NMRA | Life Sciences | $69.7M | 3 | Financial ResultsNov 16, 2026 |
| 3057 | Corbus Pharmaceuticals Holdings, Inc.NASDAQ: CRBP | Life Sciences | $69.5M | 6 | Clinical Trial DataNov 16, 2026 |
| 3058 | Ascend Wellness Holdings, Inc.OTC: AAWH | Life Sciences | $69.4M | 2 | Financial ResultsNov 12, 2026 |
| 3062 | Medicinova IncNASDAQ: MNOV | Life Sciences | $68.7M | 3 | Leadership ChangeNov 16, 2026 |
| 3067 | Tenax Therapeutics, Inc.NASDAQ: TENX | Life Sciences | $67.4M | 3 | Financial ResultsNov 5, 2026 |
| 3069 | Gossamer Bio, Inc.NASDAQ: GOSS | Life Sciences | $67.2M | 6 | Financial ResultsNov 10, 2026 |
| 3077 | Cardiff Oncology, Inc.NASDAQ: CRDF | Life Sciences | $65.9M | 5 | Financial ResultsNov 12, 2026 |
| 3079 | Atara Biotherapeutics, Inc.NASDAQ: ATRA | Life Sciences | $65.2M | 2 | Financial ResultsNov 10, 2026 |
| 3080 | Champions Oncology, Inc.NASDAQ: CSBR | Life Sciences | $65.1M | 1 | Shareholder MeetingOct 16, 2026 |
| 3088 | Fitlife Brands, Inc.NASDAQ: FTLF | Life Sciences | $64.1M | 1 | Financial ResultsNov 16, 2026 |
| 3093 | Acrivon Therapeutics, Inc.NASDAQ: ACRV | Life Sciences | $62.7M | 4 | Financial ResultsNov 16, 2026 |
| 3095 | Maia Biotechnology, Inc.NYSE: MAIA | Life Sciences | $62.4M | 4 | Clinical Trial DataNov 17, 2026 |
| 3096 | Viskase Holdings, Inc.OTC: VISK | Life Sciences | $62.3M | 1 | Financial ResultsNov 3, 2026 |
| 3107 | Insight Molecular Diagnostics Inc.NASDAQ: IMDX | Life Sciences | $60.9M | 3 | Financial ResultsNov 16, 2026 |
| 3109 | Cognition Therapeutics IncNASDAQ: CGTX | Life Sciences | $60.8M | 3 | Financial ResultsNov 5, 2026 |
| 3118 | PharmaCyte Biotech, Inc.NASDAQ: PMCB | Life Sciences | $59.8M | 2 | Reverse Stock SplitNov 13, 2026 |
| 3119 | Lifevantage CorpNASDAQ: LFVN | Life Sciences | $59.8M | 5 | Insider SellingNov 16, 2026 |
| 3133 | Boundless Bio, Inc.NASDAQ: BOLD | Life Sciences | $56.9M | 5 | Financial ResultsNov 10, 2026 |
| 3135 | XBiotech Inc.NASDAQ: XBIT | Life Sciences | $56.4M | 4 | Insider BuyingNov 13, 2026 |
| 3137 | Cingulate Inc.NASDAQ: CING | Life Sciences | $56.1M | 4 | Financial ResultsNov 13, 2026 |
| 3138 | Tonix Pharmaceuticals Holding Corp.NASDAQ: TNXP | Life Sciences | $56M | 7 | Court & Legal UpdateNov 13, 2026 |
| 3144 | Spero Therapeutics, Inc.NASDAQ: SPRO | Life Sciences | $55.1M | 5 | Financial ResultsNov 12, 2026 |
| 3145 | Verrica Pharmaceuticals Inc.NASDAQ: VRCA | Life Sciences | $55M | 2 | Financial ResultsNov 13, 2026 |
| 3149 | Adial Pharmaceuticals, Inc.NASDAQ: AZR | Life Sciences | $54.4M | 8 | Financial ResultsNov 12, 2026 |
| 3150 | Xilio Therapeutics, Inc.NASDAQ: XLO | Life Sciences | $54.4M | 2 | Financial ResultsNov 10, 2026 |
| 3152 | Heron Therapeutics, Inc.NASDAQ: HRTX | Life Sciences | $54.1M | 4 | Financial ResultsNov 9, 2026 |
| 3161 | Clene Inc.NASDAQ: CLNN | Life Sciences | $52.7M | 5 | Financial ResultsNov 4, 2026 |
| 3165 | Eloxx Pharmaceuticals, Inc.NASDAQ: ELOX | Life Sciences | $52.1M | 3 | Financial ResultsNov 16, 2026 |
| 3166 | Greenland Mines LtdNASDAQ: GRML | Life Sciences | $51.9M | 6 | Financial ResultsNov 16, 2026 |
| 3177 | Quantum Cyber N.V.NASDAQ: QUCY | Life Sciences | $51M | 7 | Financial ResultsNov 13, 2026 |
| 3185 | Citius Oncology, Inc.NASDAQ: CTOR | Life Sciences | $49.7M | 4 | Clinical Trial DataNov 4, 2026 |
| 3186 | Sangamo Therapeutics, IncOTC: SGMOQ | Life Sciences | $49.7M | 3 | Business UpdateOct 27, 2026 |
| 3196 | Werewolf Therapeutics, Inc.NASDAQ: HOWL | Life Sciences | $48.2M | 2 | Financial ResultsNov 13, 2026 |
| 3197 | MiNK Therapeutics, Inc.NASDAQ: INKT | Life Sciences | $48M | 3 | Financial ResultsNov 12, 2026 |